Synopsis of recent research by authors named "Xiong Zou"
- Xiong Zou's recent research primarily focuses on innovative treatment strategies for nasopharyngeal carcinoma (NPC), exploring combinations of immunotherapy and chemotherapy to improve outcomes for patients who are ineligible for standard cisplatin-based treatments and other therapies.
- Studies conducted on various combinations, such as gemcitabine with toripalimab and the use of low-temperature plasma radiofrequency ablation for localized recurrent NPC, indicate promising survival benefits and safety profiles, with phase II trial results shedding light on their effectiveness.
- Additionally, Zou's work extends to prognostic factors across different cancers, including bladder cancer and kidney renal clear cell carcinoma, emphasizing the role of tumor microenvironment components and cancer-associated fibroblasts in treatment responses and survival predictions.
